The basis for competition in healthcare is shifting dramatically at a pace not seen over the past 30 years. In the face of escalating costs, quality challenges and disparities in access to care, along with continued economic pressures in Europe, companies across all healthcare sectors are reassessing how best to serve and succeed in the market.

In the context of the UK, with the NHS facing a multi-billion pound budget shortfall over the coming years, key challenges remain in driving improvements in quality and integration of care delivery to ensure that people live healthier as well as longer lives. On the private side, cost-effective patient-centred solutions are needed to drive profitable growth and improvement in overall population health outcomes.

Through all the uncertainty, what is clear is that organisations will need to demonstrate measurable value, embrace the changing role of the consumer in healthcare, and harness fast-paced advances in medical science, if they are to succeed in addressing these challenges. These are not issues that will be solved by one segment of the industry alone. A deep understanding of all stakeholders, engagement beyond single sectors, embracing new uses of technology, and an ability to innovate will be required.

PwC’s strategy consulting team Strategy& works with leading healthcare organisations in the UK and around the globe to navigate the different bases of competition and build the capabilities to deliver on that promise. As part of the PwC network of firms, we can tap and connect broader resources, including PwC’s UK public sector health, life sciences and deals capabilities, to enable a truly holistic offering. Additional details on how we combine deep industry knowledge with extensive functional expertise to help our clients succeed can be found on our individual client pages: Life sciences, Health systems and other providers, Government healthcare and Health NGOs and advocacy organisations.

read more >

read more
Riding a wave of policy turmoil, consumer empowerment, and tightening margins, payors and providers have no choice but to go bold.

Our thought leadership

read more
The days of the disengaged health consumer are numbered. Consumerisation will transform healthcare systems, involving individuals as never before in the management of their own care.
In the post-reform healthcare environment, pharmaceutical companies have a clear opportunity to play a greater role in delivering a better experience for patients, improving clinical outcomes, and reducing the total cost of care. The key is digital health technology.
read more
Breakthroughs in pharmaceutical innovation are poised to change the prevailing business model of the industry — with dramatic effects on healthcare costs and practice.
read more
To better understand both the challenges faced by the global pharmaceutical industry in its pursuit of emerging-market opportunities and the strategies that leaders are employing to address them, Strategy& surveyed executives from more than 25 of the top pharmaceutical and generics companies, other industry experts, and members of Strategy&’s global pharmaceutical practice. The results paint a compelling picture of the hurdles and opportunities Pharma faces in pursuing perhaps its best opportunity for growth.
read more
Many hospitals and healthcare systems are not prepared for the way their function and forms will change in the next few years. They appear to be stuck, as if waiting for competitors, regulators, and payors to tell them how to define themselves. With a capabilities-driven strategy that broadens their thinking about form and function, hospitals and health systems can untether themselves from the past, unlock new opportunities, and remain viable and vital during these tumultuous times.
read more
Medtech companies must take the right strategic approach to managing costs while investing in capabilities and growth initiatives, via a Fit for Growth transformation.
read more
Our annual bundles survey results share the attitudes and perceptions of key stakeholders toward bundled care.
read more
New competitors in the health industry may soon be able to offer plans with cost as much as 80 percent lower than those of a typical plan today.
read more
Now that private exchanges are entering the market, the large employers that most exchanges are targeting may not be the most attractive.
read more
The goal of extending healthcare to all Americans at affordable prices and with no sacrifice in quality, will require huge changes.
read more
The Supreme Court’s decision to uphold the Affordable Care Act (ACA) means that the transformational changes already underway in the healthcare system will accelerate in three key areas.
read more
The business model that drove the major drugmakers’ success isn’t working anymore. The survivors will be those that make smart strategic bets supported by winning capabilities.
read more
As reform legislation makes the U.S. healthcare industry more consumer-centric, companies will need to change their business models and add new capabilities.

read more health thought leadership >


How we help our clients

For more than four decades, Strategy& has been serving leading institutions across all sectors of the healthcare industry:

Life sciences

We work with blue-chip life sciences companies worldwide throughout all major sectors (pharma, biotech, medical devices, diagnostics). We bring a truly differentiated ability to not only develop strategy but also help deliver value, build and embed new capabilities, and effect change.

read more >

Health systems and other providers

We work with major physician and hospital organisations in the provider sector. Our work includes creating innovative new business models and working with hospitals to restructure their enterprises to improve access to high-quality care.

read more >

Government healthcare

We serve government organisations worldwide, including in Europe, the Middle East, and Asia. We also collaborate with the premier healthcare consulting firm to the U.S. federal government, which brings more than 50 years of experience working with most health-related agencies to the engagement.

read more >

Health NGOs and advocacy organisations

We partner with nongovernmental organisations worldwide to help advance a variety of health-related missions.

read more >

We have a broad and deep set of capabilities in our service offering to address the complex issues faced by our clients:

Strategy and leadership
  • Corporate portfolio strategy
  • Market and business strategy
  • International expansion
  • M&A strategy and due diligence (including PE/VC)
  • Emerging market entry strategy

Operations and logistics
  • Complexity management
  • Strategic sourcing
  • Operational excellence
  • Differentiated supply chain
  • Lean organisation and processes
  • Integrated business planning

  • Market entry and growth strategy
  • Sales and marketing excellence
  • Pricing and market access
  • Commercial trade channel strategies

  • Multichannel marketing innovation
  • Multi-stakeholder digital solutions
  • Conceptual solutions architecture design
  • Country-level e-health solutions

R&D and innovation
  • Innovation strategy
  • Ideation and concept development
  • Project selection and prioritisation
  • Product development and testing
  • Portfolio management

Organisation and change
  • Employee engagement and culture change
  • Organisational effectiveness and alignment
  • Postmerger integration
  • Customer-centricity